| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_386990bbd8a056559026f33a129ae3ff |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-621
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-355 |
| filingDate |
1996-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f87f61ca58d7bbe98f053ef206b56a22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45a925873431c364d71c59a3b99ff22e |
| publicationDate |
1997-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H09263538-A |
| titleOfInvention |
Stable pharmaceutical composition based on acetylsalicylic acid and tocopherol |
| abstract |
(57) Abstract: A daily dose ratio for the treatment or prevention of cardiovascular diseases or additional treatment in cancer chemotherapy in order to limit the side effects of the active principle used in the treatment. To provide a novel and stable pharmaceutical composition based on acetylsalicylic acid and tocopherol suitable for oral administration of. Acetylsalicylic acid and tocopherols for oral administration comprising a capsule containing acetylsalicylic acid in crystalline or powder form in combination with tocopherol or one of its pharmaceutically acceptable salts or esters. Use of acetylsalicylic acid in crystalline or powder form for the manufacture of a medicament based on acetylsalicylic acid and tocopherol for the treatment or prevention of cardiovascular diseases or for the additional treatment in cancer chemotherapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008542316-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101347522-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2003080075-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008534591-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4509574-B2 |
| priorityDate |
1995-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |